Enjin

Ingine is a life sciences technology company that leverages quantum mechanics principles and advanced probabilistic mathematics to revolutionize drug discovery and personalized medicine. Co-founded by Dr. Barry Robson, a former Chief Science Officer at IBM's Global Life Sciences division, the company focuses on analyzing complex medical and healthcare data to generate actionable knowledge for creating better medicines. Ingine's platform is designed to tackle challenges in oncology and rare diseases by providing deep insights into patient segmentation and real-world evidence. The company aims to accelerate drug development timelines and reduce costs through its unique computational approach to biological data.